This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
PETQ or BSX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PETQ vs. BSX: Which Stock Is the Better Value Option?
Are Investors Undervaluing PetIQ (PETQ) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
PETQ or BSX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PETQ vs. BSX: Which Stock Is the Better Value Option?
Can PetIQ (PETQ) Climb 101% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for PetIQ (PETQ) points to a 100.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Should Value Investors Buy PetIQ (PETQ) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
PetIQ (PETQ) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, PetIQ (PETQ) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
PETQ or BSX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PETQ vs. BSX: Which Stock Is the Better Value Option?
Wall Street Analysts See a 108% Upside in PetIQ (PETQ): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 108.3% in PetIQ (PETQ). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Are Investors Undervaluing PetIQ (PETQ) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
PetIQ (PETQ) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
PetIQ (PETQ) delivered earnings and revenue surprises of 150% and 2.86%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Haemonetics (HAE) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Haemonetics (HAE) delivered earnings and revenue surprises of 18.57% and 8.60%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Chimerix (CMRX) Beats Q3 Earnings Estimates
by Zacks Equity Research
Chimerix (CMRX) delivered earnings and revenue surprises of 30.95% and 84.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate PetIQ (PETQ) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strength Seen in PetIQ (PETQ): Can Its 9.3% Jump Turn into More Strength?
by Zacks Equity Research
PetIQ (PETQ) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Do Options Traders Know Something About PetIQ (PETQ) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to PetIQ (PETQ) stock based on the movements in the options market lately.
PetIQ (PETQ) Q2 Earnings Top Estimates
by Zacks Equity Research
PetIQ (PETQ) delivered earnings and revenue surprises of 50% and 2.80%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Quanterix Corporation (QTRX) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Quanterix Corporation (QTRX) delivered earnings and revenue surprises of 0% and 20.45%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
AtriCure (ATRC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
AtriCure (ATRC) delivered earnings and revenue surprises of -6.67% and 6.26%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Value Investor Highlights: Merck, Maravai LifeSciences, Sensus Healthcare, PetIQ and AbbVie
by Zacks Equity Research
Merck, Maravai LifeSciences, Sensus Healthcare, PetIQ and AbbVie have been highlighted in this Value Investor article.
5 Cheap Healthcare Stocks in 2022
by Tracey Ryniec
Looking for value stocks? Healthcare has been ignored over the last year.
PETQ vs. BSX: Which Stock Is the Better Value Option?
by Zacks Equity Research
PETQ vs. BSX: Which Stock Is the Better Value Option?
PetIQ (PETQ) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
PetIQ (PETQ) delivered earnings and revenue surprises of 67.57% and 2.36%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
PetIQ (PETQ) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
PetIQ (PETQ) delivered earnings and revenue surprises of -200% and 15.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in PetIQ (PETQ): Can Its 7.1% Jump Turn into More Strength?
by Zacks Equity Research
PetIQ (PETQ) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Does PetIQ (PETQ) Have the Potential to Rally 87% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 86.5% in PetIQ (PETQ). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.